Skip to content
Open access

Medium-term prediction of clinically relevant outcomes in first-episode schizophrenia patients.

Aug 2026 · Schizophrenia Research · Vol 297, pp. 89-96 · 0 citations · 44 references
Medicine

TL;DR

Negative symptoms are an exception: comparatively stable after initial treatment and predictable from baseline, with past symptomatology along with DUP selected as predictors - indicating stronger persistency and predictability than in the other two investigated outcomes.

Abstract

Background

Predicting long-term outcomes in first-episode schizophrenia (FES) remains difficult, despite being especially important early in the illness, when timely intervention is most critical. It also remains unclear how much data from the initial phase of illness is required to improve prognostic accuracy.

Methods

We analysed 68 FES patients assessed at baseline (V1; mean 0.5 years post-onset), one-year follow-up (V2; mean 1.2 years), and outcome (V3; mean 4.9 years). Elastic-net models were trained to predict three V3 outcomes - negative symptoms (PANSS Negative factor; Wallwork/Fortgang), global functioning (GAF), and quality of life (WHOQOL-BREF psychological domain) - using either V1 predictors alone (23 variables) or V1 + V2 combined (43 variables). Performance was evaluated using nested cross-validation on held-out data.

Results

With V1 + V2 predictors, all three outcomes were predicted at statistically significant levels: PANSS Negative R2 = 0.22 (driven by log(DUP), PANSS Negative at V1/V2, and PANSS Disorganised at V2); WHOQOL-BREF Psychological Health R2 = 0.22 (driven by WHOQOL Psychological Health and GAF at V2); and GAF R2 = 0.14 (driven by GAF, PANSS Positive, WHOQOL Psychological Health at V2, and hospitalisation burden). With V1 predictors alone, only PANSS Negative showed meaningful predictive power (R2 = 0.15); GAF and WHOQOL-BREF did not outperform the intercept-only baseline.

Conclusion

Long-term functioning and quality of life in FES cannot be predicted from first-episode data alone; at least one year of follow-up is required, suggesting post-onset changes shape these outcomes. Negative symptoms are an exception: comparatively stable after initial treatment and predictable from baseline, with past symptomatology along with DUP selected as predictors - indicating stronger persistency and predictability than in the other two investigated outcomes.

Read PDF

Similar papers

Open access Aug 2026

Trajectory-Based Modeling Improves Long-Term Outcome Prediction Beyond 90-Day Assessment in ICU-Treated Intracerebral Hemorrhage

ICU-treated patients with spontaneous intracerebral hemorrhage exhibit distinct long-term recovery trajectories that are strongly associated with quality of life, supporting a shift toward dynamic outcome modeling for long-term prognostication in ICH.

Qing Su, Xi-Ni Zhang, Bao-Gu Wang et al. · 0 citations
Review Sep 2026

Toward precision medicine: can neuroimaging prospectively predict early treatment outcomes in schizophrenia spectrum disorders? A systematic review and meta-analysis.

Baseline neuroimaging may provide relevant prognostic information in Schizophrenia Spectrum, support that treatment response may be related to disturbances in large-scale network organization than to isolated structural abnormalities, and support the potential of prognostic neuroimaging in precision psychiatry and earl...

Claudio Caiazza, Giancarlo Fusco, L. Ugga et al. · 0 citations
Open access Aug 2026

Mapping 20-Year Global Functioning Trajectories in Schizophrenia Spectrum Disorders.

At the 20-year follow-up, individuals in the Functional recovery trajectory demonstrated the most favorable outcomes, while those in the Impaired functioning trajectory exhibited the poorest outcomes across all key domains.

M. Abella, H. G. Hansen, C. Hjorthøj et al. · 0 citations
Open access Aug 2026

Association between baseline cognition and clinical response in first-episode schizophrenia

This study aimed to investigate the association between baseline cognitive performance and the clinical response to antipsychotics in first-episode schizophrenia (FES) patients. This study examined 769 patients from a multi-center research cohort. Neurocognition was measured using the MATRICS Consensus C...

Yuanyuan Zhu, Ye Yang, Ren-Rong Wu et al. · 0 citations
Open access Sep 2026

580. Clinical treatment pathways of antipsychotics in patients with schizophrenia spectrum disorder: a retrospective longitudinal observational study

This analysis of antipsychotic prescribing for first-episode SSD from 2014-2019 found quetiapine, olanzapine, aripiprazole, risperidone, and amisulpride were the most common initial agents, and the shift toward quetiapine aligns with international trends.

Q. Bo, T. Li, Y. Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.